Complement and circulating immune complexes in children with mumps meningitis. 1984

K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch

Haemolytic activity of complement (CH50) and occurrence of circulating immune, complexes (CIC) were studied in serum samples from children with mumps meningitis taken at regular intervals. The decrease of CH50 was observed in 46 out of 77 samples (60%) in the Ist examination, between 1-6th day from the appearance of symptoms, in 43/67 samples (64%) in the IInd examination, between 12--16th day of disease, and in 7/22 samples (32%) in the IIIrd examination, between 12--14th month of observation since the appearance of symptoms. Typical changes of complement level during the disease were of such profile that the most pronounced decrease was in the Ist and IInd examination with the normalization in the IIIrd examination. The presence of CIC was found in 21%, 15% and 14% of samples in the Ist, IInd, and IIIrd examination respectively. Serum sample form the child on 5th day of disease, with high concentration of CIC (482 micrograms/ml), was subjected to sepharose 6B gel filtration on the calibrated column. The molecular weight of thus analyzed immune complexes was as follows: 2.5 X 10(6) and 5.0 X 10(5) daltons. CIC contained anti-mumps antibodies, determined by Elisa, in IgG, IgA and IgM classes.

UI MeSH Term Description Entries
D008587 Meningitis, Viral Viral infections of the leptomeninges and subarachnoid space. TOGAVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; RUBELLA; BUNYAVIRIDAE INFECTIONS; ORBIVIRUS infections; PICORNAVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RHABDOVIRIDAE INFECTIONS; ARENAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; JC VIRUS infections; and RETROVIRIDAE INFECTIONS may cause this form of meningitis. Clinical manifestations include fever, headache, neck pain, vomiting, PHOTOPHOBIA, and signs of meningeal irritation. (From Joynt, Clinical Neurology, 1996, Ch26, pp1-3) Viral Meningitis,Meningitides, Viral,Viral Meningitides
D009107 Mumps An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed) Parotitis, Epidemic,Epidemic Parotitides,Epidemic Parotitis,Parotitides, Epidemic
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D003165 Complement System Proteins Serum glycoproteins participating in the host defense mechanism of COMPLEMENT ACTIVATION that creates the COMPLEMENT MEMBRANE ATTACK COMPLEX. Included are glycoproteins in the various pathways of complement activation (CLASSICAL COMPLEMENT PATHWAY; ALTERNATIVE COMPLEMENT PATHWAY; and LECTIN COMPLEMENT PATHWAY). Complement Proteins,Complement,Complement Protein,Hemolytic Complement,Complement, Hemolytic,Protein, Complement,Proteins, Complement,Proteins, Complement System
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000936 Antigen-Antibody Complex The complex formed by the binding of antigen and antibody molecules. The deposition of large antigen-antibody complexes leading to tissue damage causes IMMUNE COMPLEX DISEASES. Immune Complex,Antigen-Antibody Complexes,Immune Complexes,Antigen Antibody Complex,Antigen Antibody Complexes,Complex, Antigen-Antibody,Complex, Immune,Complexes, Antigen-Antibody,Complexes, Immune

Related Publications

K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
September 1981, Journal of clinical & laboratory immunology,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
January 1985, Terapevticheskii arkhiv,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
March 2005, African journal of medicine and medical sciences,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
January 1984, Annales de biologie clinique,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
April 1991, Indian journal of pathology & microbiology,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
February 1984, Pediatriia,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
January 1991, Pediatriia,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
January 1989, Klinika oczna,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
July 1981, Alergia,
K Madaliński, and D Imbs, and H Gregorek, and M Jankowski, and G Ułanowicz, and W Gut, and M Kańtoch
March 1980, Clinical and experimental immunology,
Copied contents to your clipboard!